Global Drug Screening Market is estimated at $4.8 Bn (2020) growing at a CAGR of 15.8% through 2020-2025. The market growth is driven by growing drug use after COVID-19 pandemic and increase in abuse ...

Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert® HIV-1 Viral Load XC, a next-generation extended-coverage (XC) test intended to aid in assessing HIV ...

HepQuant, LLC, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is proud to announce ISO 13485 certification as its latest milestone in operational ...

As researchers work to improve treatment of Alzheimer’s disease, new research by UCLA Health identified a candidate drug that ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

President Donald Trump will reintroduce a sweeping Medicare drug-pricing plan that failed to advance in his first term.

Bloodstream infections caused by yeast rose by 4% in 2024, compared to 2023. Latest data from UK Health Security Agency ...

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of ...

Evidence is mounting that clinicians can treat serious genetic disorders prenatally by injecting medicine into the amniotic fluid, thus preventing damage that begins in utero.

Although the preferred target in the RAS was renin, at the top of the cascade, it was another 20 years before the first inhibitors of renin were available for clinical research. The discovery and ...

It had approved the trial and the drug had already been tested on animals and in a laboratory. Volunteers are paid up to £150 a day to take part in clinical trials. Healthy volunteers are used to test ...